ClinicalTrials.gg
RecruitingNCT07819929Metal-free OTTUpdated Nov 10, 2026

Mid-term Postoperative Clinical Evaluation of Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction Using the Over-The-Top Technique, Fixed With Metal Staples or Soft Anchors.

An interventional study of ACL reconstruction using the Over-The-Top technique in ACL Reconstruction and Fixation, sponsored by Stefano Zaffagnini. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Stefano Zaffagnini · Not applicable, Interventional, and Treatment

Updated Nov 10, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Anterior cruciate ligament (ACL) reconstruction is a widely performed procedure aimed at restoring knee stability and enabling return to sports activities. The Over-The-Top (OTT) technique is a well-established option, particularly in complex and revision cases, due to its ability to provide both anteroposterior and rotational stability. Long-term studies have reported favorable clinical outcomes, with low failure rates.

Graft fixation is an important technical aspect that may influence postoperative outcomes. Traditionally, the OTT technique has been performed using metal staples, which provide reliable primary fixation but may cause local complications and sometimes require subsequent removal due to pain or discomfort.

More recently, suture-based fixation devices, such as Knee FiberTak anchors (Arthrex), have been introduced as a metal-free alternative. These devices allow graft fixation through high-strength sutures, providing stable graft-to-bone contact while minimizing bony invasiveness and hardware prominence.

The present study aims to evaluate the clinical, functional, and instrumental outcomes of ACL reconstruction using the OTT technique with graft fixation by suture anchors compared with traditional metal staples. Particular attention will be paid to postoperative knee stability, assessed using validated instruments (KT-1000 and KiRA), as well as failure rates, reoperations, and complications.

02

Conditions studied

  • ACL Reconstruction
  • Fixation
03

In context

Lead sponsor

Stefano Zaffagnini is the lead sponsor of 13 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients of either sex, aged between 18 and 50 years at the time of surgery;
  2. Patients with an isolated anterior cruciate ligament (ACL) injury, with or without associated meniscal lesions, scheduled for ACL reconstruction and meniscal treatment; .3 Patients whose contralateral knee has never undergone meniscectomy, ligament reconstruction, unicompartmental knee arthroplasty, or total knee arthroplasty;

4. Patients who have signed the form.

Exclusion criteria

Exclusion Criteria:

  1. Patients with associated injury of the medial collateral ligament (MCL), lateral collateral ligament (LCL), posterolateral corner (PLC), or posterior cruciate ligament (PCL);
  2. Patients with complete meniscal root tears, complete radial tears, or lateral meniscus oblique tears (LMORT);
  3. Patients who underwent total or subtotal medial or lateral meniscectomy;
  4. Patients with grade III-IV chondral lesions according to the Outerbridge classification identified at the time of surgery;
  5. Patients who are unable to provide or who are unwilling to provide informed consent;
  6. Patients with insufficient and/or compromised bone quality or quantity due to disease, infection, or previous implantation, such that adequate support and/or fixation of the devices cannot be ensured;
  7. Patients with limited blood supply or a history of infections that could delay healing;
  8. Patients with sensitivity to foreign materials.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Active comparator
    Metal staples

    Procedure: ACL reconstruction using the Over-The-Top technique

  • Experimental
    Soft anchors

    Procedure: ACL reconstruction using the Over-The-Top technique

Interventions

  • ProcedureACL reconstruction using the Over-The-Top technique

    The procedure involves ACL reconstruction using the Over-The-Top technique, with the graft positioned over the lateral femoral condyle to provide anteroposterior and rotational stability. The graft is secured using either metal staples or suture anchors, according to the assigned fixation technique.

06

What researchers measure

Primary outcomes

  1. KT-1000

    The KT-1000 is a clinical-instrumental test widely used for the standardized assessment of patients undergoing anterior cruciate ligament (ACL) reconstruction. It provides an objective measurement of anterior-posterior knee laxity and is extensively used in both clinical practice and scientific research. The assessment is performed with the patient in a supine position, with the knee flexed to approximately 30° and supported on a dedicated device. The examiner applies a standardized anterior load to the tibia while stabilizing the femur, and the resulting anterior-posterior displacement is recorded by sensors positioned in contact with the patella and tibial tuberosity. The measurement does not have a predefined minimum or maximum value. Lower values indicate less anterior laxity and therefore better knee stability, whereas higher values indicate greater anterior laxity and worse knee stability.

    Time frame: At least 24 months

Secondary outcomes

  1. KiRA

    For quantitative assessment of the Pivot Shift test, the KiRA sensor is secured to the skin over the anterolateral proximal tibia, specifically at the level of Gerdy's tubercle, using a hypoallergenic strap and an appropriate support to optimize stability. The device, which incorporates a triaxial accelerometer and gyroscope, communicates wirelessly with a dedicated application installed on a tablet, providing real-time quantification of tibial displacement during the clinical maneuver. KiRA measurements are expressed in millimeters (mm) and represent the magnitude of anterior tibial displacement. There is no predefined minimum or maximum value for this continuous measurement; lower values indicate less tibial displacement and therefore better rotational stability, whereas higher values indicate greater displacement and worse rotational stability.

    Time frame: At least 24 months

  2. IKDC standard evaluation form

    This is a clinical assessment form completed by the physician following a thorough physical examination of the knee. It includes several clinical tests to assess joint deformities, objective instability, and meniscal injuries. The resulting score determines an objective functional grade, classified from A to D: \*\*A\*\*, normal; \*\*B\*\*, nearly normal; \*\*C\*\*, moderately abnormal; and \*\*D\*\*, severely abnormal.

    Time frame: At least 24 months

  3. Lysholm Knee Score

    This is a validated outcome measure that assesses knee function through 8 items designed to evaluate the knee's ability to meet the functional demands of daily activities. It is commonly used to assess surgical outcomes in patients undergoing treatment for knee ligament or meniscal injuries. The final score is calculated by summing the scores obtained across the individual items, ranging from 0 to 100. Scores are classified as \*\*Excellent (95-100), Good (84-94), Fair (65-83), and Poor (\<64)\*\*.

    Time frame: At least 24 months

  4. VAS

    This is a 10-point unidimensional numerical scale used to assess pain intensity. The patient selects the number that best represents their pain intensity at that specific moment, ranging from 0 (no pain) to 10 (worst possible pain)

    Time frame: At least 24 months

  5. SF-12 (Short Form-12 Health Survey)

    This is a 12-item multiple-choice questionnaire that provides two main summary measures: the \*\*Physical Component Summary (PCS)\*\* and the \*\*Mental Component Summary (MCS)\*\*. Together, these scores provide a concise and reliable assessment of the patient's overall health status. Scores are typically reported on a 0-100 scale, with higher scores indicating better health-related quality of life.

    Time frame: At least 24 months

  6. KOOS (Knee Injury and Osteoarthritis Outcome Score)

    This is a validated, knee-specific outcome measure used to assess symptoms and function in patients with ligament injuries or degenerative knee conditions. It consists of five subscales: \*\*Pain, Other Symptoms, Activities of Daily Living (ADL), Sport and Recreation Function, and Knee-Related Quality of Life (QOL)\*\*, providing a comprehensive assessment of the impact of knee pathology and treatment on joint function and quality of life. Each subscale is scored from 0 to 100, with higher scores indicating better knee function and fewer symptoms, while lower scores indicate worse outcomes.

    Time frame: At least 24 months

  7. Tegner Score

    The Tegner Activity Scale is a validated measure used to assess the patient's level of physical activity on a scale from \*\*0 to 10\*\*, where 0 represents disability and 10 represents participation in competitive sports at a national or international level, such as football. It is widely used to assess activity levels in patients with knee disorders. Patients will also be asked how many years they have been physically active in sports and whether any reduction or cessation of sporting activity is related to their knee condition.

    Time frame: At least 24 months

  8. Patient Satisfaction

    To assess the patient's level of satisfaction, patients will be asked the following question: "Are you satisfied with the surgical procedure?" The response will be dichotomous (yes/no)

    Time frame: At least 24 months

07

Study locations

1 of 1 sites recruiting
08

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
IRCCS Rizzoli Orthopedic Institute is now Recruiting
Nov 10, 2026
Start date
Sep 2026→Oct 13, 2026 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    IRCCS Rizzoli Orthopedic Institute is now Recruiting
    Start date Sep 2026→Oct 13, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07819929
Lead sponsor
Stefano Zaffagnini
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Sponsor-investigator
First posted
Sep 15, 2026
Start date
Oct 13, 2026
Primary completion
Aug 2030 (estimated)
Completion
Aug 2030 (estimated)
Last update
Nov 10, 2026

Study contacts

Stefano Zaffagnini
Contact
stefano.zaffagnini@ior.it
0516366075

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion